Synergia Sciences Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.55 Cr
as on 17-06-2024
- Paid Up Capital ₹ 1.53 Cr
as on 17-06-2024
- Company Age 13 YEARS, 11 MONTHS
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.57 Cr
as on 17-06-2024
- Satisfied Charges ₹ 19.04 Cr
as on 17-06-2024
- Revenue 1.69%
FY 2023
- Profit -51.45%
FY 2023
- Ebitda -26.18%
FY 2023
- Net Worth 18.46%
FY 2023
- Total Assets 5.88%
FY 2023
About Synergia Sciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.55 Cr and a paid-up capital of Rs 1.53 Cr.
The company currently has active open charges totaling ₹13.57 Cr. The company has closed loans amounting to ₹19.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Janesh Upadhyay, Sharang Parekh, and Nandini Sandip serve as directors at the Company.
- CIN/LLPIN
U24100MH2010PTC209590
- Company No.
209590
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Synergia Sciences?
Board Members(3)
Financial Performance and Corporate Structure Insights of Synergia Sciences.
Synergia Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.69% increase. The company also saw a substantial fall in profitability, with a 51.45% decrease in profit. The company's net worth Soared by an impressive increase of 18.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synergia Sciences?
In 2023, Synergia Sciences had a promoter holding of 90.69% and a public holding of 9.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aaress Life Sciences Private Limited
Active
1 year 4 months Sharang Parekh and Nandini Sandip are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 May 2022 | ₹7.90 Cr | Open |
Karnataka Bank Ltd. Creation Date: 06 May 2022 | ₹5.00 Cr | Open |
Others Creation Date: 23 Mar 2022 | ₹6.70 M | Open |
How Many Employees Work at Synergia Sciences?
Synergia Sciences has a workforce of 75 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jul 30, 2021, Synergia Sciences has raised a total of ₹ 6.07 Cr, with the most recent deal valued at ₹ 1.44 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
